NOVEL ANTIBACTERIAL PROTEIN CPEL-1 HAVING LYTIC ACTIVITY AGAINST CLOSTRIDIUM PERFRINGENS

摘要

The present invention relates to an antibacterial protein CPEL-1 which has the ability to kill Clostridium perfringens and is represented by the amino acid sequence of SEQ ID NO: 2, to a pharmaceutical composition comprising same as an active ingredient, and to a method for preventing or treating diseases caused by Clostridium perfringens using the pharmaceutical composition.